MktsMarkets

Catalyst Pharmaceuticals, Inc.
NASDAQ: CPRXKey statistics
CPRX News
Stories mentioning CPRX from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 149,390 | 152,613 | 148,392 | 146,563 | 141,421 | 141,820 | 128,695 | 122,710 |
| Cost of Goods Sold | 14,475 | 26,074 | 22,654 | 20,614 | 17,911 | 21,643 | 19,277 | 15,405 |
| Gross Profit | 134,915 | 126,539 | 125,738 | 125,949 | 123,510 | 120,177 | 109,418 | 107,305 |
| Operating Expenses | ||||||||
| Research & Development | 2,661 | 1,807 | 2,657 | 4,358 | 3,887 | 3,798 | 3,284 | 2,985 |
| Sales General & Admin | 49,319 | 53,421 | 47,470 | 45,949 | 46,911 | 44,192 | 45,880 | 40,730 |
| Total Operating Expenses | 51,980 | 55,228 | 50,127 | 50,307 | 50,798 | 47,990 | 49,164 | 43,715 |
| Operating Income (Loss) | 73,232 | 61,846 | 66,267 | 66,298 | 63,367 | 62,843 | 50,909 | 54,246 |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 10,997 | 10,055 | 4,768 | 2,995 | 7,919 | 11,338 | 6,296 | 1,542 |
| Pretax Income | 84,229 | 71,901 | 71,035 | 69,293 | 71,286 | 74,181 | 57,205 | 55,788 |
| Tax Provision | 20,495 | 19,203 | 18,252 | 17,185 | 14,549 | 18,245 | 13,321 | 14,994 |
| Net Income (Loss) | 63,734 | 52,698 | 52,783 | 52,108 | 56,737 | 55,936 | 43,884 | 40,794 |
| Earnings Per Share (Basic) | 0.52 | 0.43 | 0.43 | 0.43 | 0.47 | 0.47 | 0.37 | 0.35 |
| Earnings Per Share (Diluted) | 0.50 | 0.41 | 0.42 | 0.41 | 0.45 | 0.45 | 0.35 | 0.33 |
| Weighted Average Shares Outstanding (Basic) | 122,254 | 122,291 | 122,601 | 122,163 | 121,472 | 118,458 | 118,931 | 118,180 |
| Weighted Average Shares Outstanding (Diluted) | 126,903 | 127,258 | 127,090 | 127,543 | 126,958 | 124,944 | 125,407 | 124,656 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About CPRX
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is a stock listed on the Nasdaq Stock Market under the ticker symbol CPRX. It last traded at $0.0000 (Dec 31, 1969, 7:00 PM ET). That gives Catalyst Pharmaceuticals a market capitalisation of $3.9B and a price-to-earnings ratio of 17.4.
Over the past 52 weeks CPRX has traded between $20.66 and $32.56.
Revenue for the quarter ended Mar 31, 2026 was $149.4M; net income $63.7M. Revenue was up 5.6% from $141.4M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $149.4M | $63.7M | 42.7% |
| Dec 31, 2025 | $152.6M | $52.7M | 34.5% |
| Sep 30, 2025 | $148.4M | $52.8M | 35.6% |
| Jun 30, 2025 | $146.6M | $52.1M | 35.6% |
From Catalyst Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…